NIH's Role In Sustaining the U.S. Economy 2021 Update Now Available
here
UMR Urges House and Senate Leaders to Include NIH Funding in COVID Relief Package
read here
UMR releases new fact sheets on COVID-19 and biomedical research. Read
here
See how UMR members are aiding in the fight against the coronavirus
here
A new episode of the
Amazing Things Podcast is now available! Check it out
here.
The long view on COVID-19 vaccine safety and efficacy
Between December 2020 and February 2021, three drugmakers received Emergency Use Authorizations to distribute COVID-19 vaccines. The next step is a biologics license application—the technical name for full approval—a process Pfizer and Moderna have already begun. Experts from Penn are keeping a close eye on these regulatory steps, as well as the reporting mechanisms involved in assessing vaccine safety. The outlook thus far seems promising.